Ipratropium Bromide 0.03% (Ipratropium Bromide Bottles) 21mcg/spray x30ml

Ipratropium bromide works by competitively antagonizing muscarinic acetylcholine receptors (M1, M3) in the airway smooth muscle. This action inhibits the vagally-mediated reflexes that cause bronchoconstriction and increased mucus secretion, leading to bronchodilation. By relaxing the airway muscles, it helps to improve airflow and reduce symptoms of respiratory conditions.

The usual dose of Ipratropium Bromide 0.03% is determined by a healthcare provider based on the patient's condition and response to treatment. It is typically administered as two sprays per nostril two or three times daily for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children age 6 years and older.

Ipratropium Bromide is classified as a pregnancy category B drug, meaning that animal studies have not shown a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if clearly needed. For breastfeeding, it is recommended to consult a healthcare provider to weigh the benefits and potential risks.

To order Ipratropium Bromide from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the import paperwork.

Ipratropium Bromide is an anticholinergic bronchodilator that works by relaxing the airway muscles. It is often used in combination with other asthma medications, such as beta-agonists, to manage symptoms. Compared to beta-agonists, it has a different mechanism of action and may be used when other medications are not effective or well-tolerated.

Ipratropium Bromide should be stored below 25°C, kept in the original pack, and protected from moisture. Avoid freezing and ensure the medication is kept out of reach of children. Proper storage helps maintain the efficacy and safety of the medication.

Ipratropium Bromide is administered via inhalation using a metered-dose inhaler or a nebulizer. The medication is sprayed into the nostrils or inhaled into the lungs, depending on the formulation. It is important to follow the instructions provided by the healthcare provider or the product label for proper administration.

The most serious risks associated with Ipratropium Bromide include allergic reactions, worsening of narrow-angle glaucoma, urinary retention, and paradoxical bronchospasm. Patients should seek immediate medical attention if they experience symptoms such as rash, itching, swelling, blurred vision, difficulty urinating, or worsening of breathing difficulties.

Ipratropium Bromide should not be used by patients with a history of hypersensitivity to atropine or its derivatives, or to any of the other ingredients in the medication. It should also be used with caution in patients with narrow-angle glaucoma, urinary retention, and cardiovascular diseases. Always consult a healthcare provider before starting any new medication.